Watch · 56/100 · medium confidence

COLUMBIA BANKING SYSTEM, INC. (COLB) — Council Assessment

🟡 WATCH · Score 56/100 · medium confidence

A well-run regional bank at fair value — solid execution, thin margin of safety, and no catalyst edge left after a 41% run to 52-week highs.

As of 2026-06-27. 14 lenses weighed in, 4 abstained. Sources: 6 filings, 15 news, 15 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

Columbia Banking System (COLB) — Investment Briefing

Management Commentary (Q4 2025 Earnings Call)

Strategic positioning & M&A integration: CEO Clint Stein framed 2025 as a transformative year, anchored by the closed Pacific Premier Bank (PPB) acquisition—described as the "missing puzzle piece" to complete the western footprint and reach top-10 deposit share in Southern California. Management emphasized seamless cultural integration and a highly experienced integration team with 20+ conversions completed over 15 years. Systems conversion slated for Q1 2026.

Financial performance & guidance:

Q4 operating PPNR: +27% QoQ; operating net income +19% QoQ
Full-year 2025 (operating basis): PPNR +22%, net income +31% vs. 2024
Q4 EPS: $0.72 GAAP, $0.82 operating (+15% YoY)
Net Interest Margin: 4.06% Q4 (vs. 3.84% Q3, 3.64% Q4 2024)
- Benefited from $12M CD premium amortization (11 bps) + $5M accelerated loan repayment; both will not repeat in 2026
- Q1 2026 NIM guidance: 3.90–3.95% (reflecting absence of one-time benefits and seasonal deposit flows)
- Expected to exceed 4% in Q2 or Q3, trending higher through year

Loan & deposit dynamics:

Gross loans: $47.8B (down from $48.5B Q3), reflecting intentional run-off of below-market transactional loans and CRE construction/development payoffs (~85% to Fannie/Freddie
Transactional multifamily: 75–80% retention at 6.5–7% coupons; remaining exits
Customer deposits: $54.2B (down $1.6B QoQ) due to seasonal outflows and intentional reduction of brokered deposits
Modest additional deposit contraction expected Q1 (tax payments); recovery anticipated spring

Profitability & capital:

ROAA: >1.4%; ROTCE: >17%
Tangible book value: $19.11/share (+3% Q, +11% YoY)
CET1/Total risk-based capital: 11.8% / 13.6%
Dividend increased to $0.37/share (+3%); repurchased 3.7M shares at $27.07 avg
2026 buyback guidance: $150–200M/quarter (vs. 3.7M in Q4); $600M remains authorized

Cost savings & expense guidance:

Annualized deal-related synergies: $63M achieved (50% of $127M target) as of year-end; full run-rate by end of Q2
Operating non-interest expense (ex-CDI amortization): $331M in Q4 (low end of $330–340M guidance); Q1–Q2 2026 expected $335–345M, Q3 declining modestly
CDI amortization: ~$40M/quarter ongoing
Full-year 2025 operating expense: ~$1.5B

Credit quality:

Provision: $23M Q4 (stable metrics throughout 2025, "untouched by external events")
ACL: 1.02% of loans; 1.32% when including acquired loan credit discount
Special mention loans migrated to substandard (~$130M swing each direction), reflecting elongated downturn pressure, not new deterioration

Non-interest income:

Q4 operating: $88M (+$16M seq, $13M from PPB, $3M from higher customer fees)
Swap/syndication banking, treasury management, international, trust revenue all strong
Core fee income expected low-to-mid $80M range in 2026 (Q4 was "high watermark" for swaps/syndication)

Business generation:

New loan originations: $1.4B (+23% YoY); full-year +22%
Three deposit campaigns in 2025 added $1.3B low-cost deposits; retail campaign underway with expectations for continued momentum post-integration

Management tone: Clint's opening remarks and Q&A responses conveyed confidence, disciplined optimism, and operational maturity. Emphasized "profitability over growth for growth's sake" and "consistent, repeatable earnings" as legacy themes. Integration leadership projections calm and confident. No material red flags flagged in credit or liquidity.

Recent Developments

Q4 2025 earnings (24 Jan 2026): Beat EPS and revenue; PPNR and net income surged on PAC Premier contribution and balance sheet optimization.
Dividend increase (announced Nov 2025, in effect Q1 2026): Raised dividend to $0.37/share (+3%).
PAC Premier systems conversion: Scheduled for Q1 2026.
De novo expansion: New branches opened in Arizona, Colorado, California, Oregon during 2025; continued planned activity for 2026.
Share buybacks: Q4 repurchased 3.7M shares; 2026 guidance $150–200M/quarter.

Bull Narrative

From management & press:

Successful acquisition integration: PAC Premier showing strong cultural fit, minimal employee friction, healthy customer referral flow, and early win-wins (e.g., $200M revenue co. and surgical center relationships expanded). No red flags in Q&A.
Margin expansion momentum: NIM rose 22 bps QoQ despite rate cuts; management projects margin to exceed 4% by Q2–Q3 and continue trending higher as deposit costs normalize and balance sheet optimization gains flow through. Full annualized synergies ($127M) will be realized by end Q2.
Operational leverage & excess capital: ROE >17%, ROAA >1.4%; management committing to $150–200M/quarter buybacks (multi-year plan). Tangible book value +11% YoY signals strong internal capital generation.
Disciplined portfolio pruning: Intentional run-off of below-market transactional loans being replaced with 6.5%+ core relationships; CRE construction runoff at expected pace; credit stable.
Fee income upside: Treasury, wealth/custodial trust, international, and syndication businesses all ramping; PAC Premier's $40M deposit trust platform complementary.
Retail/deposit strength: Three campaigns generated $1.3B low-cost deposits in 2025; deposit playbook proven effective in managed rate environment.

From retail investors:

Long-term holders celebrating 100%+ returns (capturing dividends + cap gains); stock described as "amazing run."
Technical bullish calls: "Forty coming" (Feb 2026 post at $32); chart watchers eyeing $35 target; options traders noting cheap near-term call premiums pre-earnings.
One analyst note (Zacks, Jan 2026): "Strong Q4 beat—revenue growth did the heavy lifting."

Bear Narrative

From management (cautiously disclosed risks):

NIM one-time boost winding down: $12M CD premium and $5M accelerated loan repayment totaled 11 bps of Q4 margin benefit and will not repeat in 2026. Q1 margin guidance (3.90–3.95%) reflects this cliff, creating QoQ decline noise.
Transactional loan runoff ongoing: $2.8B transactional portfolio will continue to amortize down; while 75–80% retention is expected, 20–25% will exit. Relies on ability to backfill with 6.5%+ core relationships in a slowing economy.
Seasonal deposit headwinds: Expected Q1 contraction (tax payments) before spring recovery; if economy weakens, recovery timing uncertain.
Expense guidance high-end risk: Q1–Q2 non-interest expense in $335–345M range (before realizing all synergies); any delays in cost-save realization or unplanned investments could pressure margins.
Acquisition execution risk: Systems conversion in Q1 is "the last hurdle"; while management confident, large integrations historically carry tail risks (customer/employee attrition, system downtime, revenue disruption).

From market chatter (sparse but skeptical notes):

One retail post (Jan 2026): "[Bullish] And yet the stock price falls — what the actual F?" — suggests frustration with stock not tracking strong earnings.
Technical support levels mentioned (e.g., "$26.78" in Feb, "$28.74" in May) imply pullback risk if broader market turns.
Limited bear-specific commentary in provided material; no short theses or activist warnings.

Retail Sentiment

Overall: Bullish with mixed short-term conviction.

Long-term holders: Highly bullish; celebrating multi-year returns and planning holds. Tone: satisfied, patient, dividend-focused.
Options traders: Moderately bullish, tactical; betting on $30–$35 calls with 50–75% ROI targets over 4–6 months; described as "cheap" premium opportunities pre-earnings.
Technical traders: Bullish bias but acknowledging "range-bound" or "sideways" consolidation near $29–$32 (as of May–Jun 2026); one post noted "needs upside breakout."
Sentiment on earnings: Mixed—strong Q4 beats appreciated, but stock price action post-beat disappointing to some (Jan 2026 frustration post).
Conviction level: Moderate overall; no FOMO or euphoria tone; mostly methodical dividend and growth holders.

Caveats

Coverage & data quality:

Earnings call transcript poor audio quality: Numerous transcription errors ("Columbia Biking System," garbled names, incomplete sentences) make some remarks ambiguous. Key facts cross-checked against press release, but nuance may be lost.
Limited sell-side coverage in material: Only Zacks brief note and analyst questions (RBC, Barclays, KBW, JP Morgan, DA Davidson, Freeman James) provided; no independent equity research summary.
Sparse retail discussion: Only ~15 forum posts across 6+ months; not representative of broader retail sentiment. Options-trader material is technical/tactical, not fundamental.
Recent news URL headers only: Latest news (Jun 2026) appears to be insider selling ($3.9K share sales by EVP Devine) and generic dividend/forecast articles; no new material facts.

Hype & execution risks to discount:

Management's "seamless integration" and "calm, confident" team commentary is self-serving. Conversions routinely surface unforeseen issues; Q1 2026 execution will be the true test.
NIM guidance assumes deposit normalization ("modest contraction in Q1, recovery in spring"). Recession or deposit flight would invalidate this path.
Synergy realization ($127M) is on track by management's account, but full-year 2026 expense guidance ($335–345M Q1–Q2 ex-CDI) is at the high end, leaving little margin for error.
Stock price action post-Q4 beat (falling, per retail comment) suggests market may be pricing in execution risk or seeing valuation as full after the run.

What's not covered:

Competitor dynamics (no mention of regional bank stress, deposit competition, or strategic shifts by peers).
Macro sensitivity (interest rate path, recession probability) implicit but not explored.
Regulatory environment (no mention of capital rules, lending stress tests, or compliance risks).
Customer concentration or sector exposure in loan portfolio (limited detail on CRE exposure post-transaction).

Summary

Columbia Banking delivered a strong Q4 2025 anchored by PAC Premier contribution and disciplined balance sheet optimization. Management guided conservatively on 2026 NIM (expecting a dip to 3.90–3.95% in Q1, then recovery), maintaining profitability focus and executing a multi-year capital return program ($150–200M buybacks/quarter). Credit remains stable; integration appears on track.

Key risks: One-time NIM tailwinds winding down; transactional loan runoff; Q1 systems conversion execution; deposit normalization assumptions. Stock has already risen substantially; near-term sentiment bullish but conviction mixed on continued upside. Suitable for patient, yield-focused investors comfortable

Bull case

COLB is a competently managed Pacific Northwest/SoCal regional bank harvesting synergies from the Pacific Premier acquisition ($63M of $127M target achieved, full run-rate by Q2 2026). It trades at ~0.98x reported book with operating ROTCE >17%, ROAA >1.4%, solid CET1 of 11.8%, and returns capital aggressively via a rising dividend (~4.6% yield) and $150-200M/quarter buybacks. Greenwald (72) and the disruption referee (72) note the deposit franchise carries a real if narrow moat protected by a regulatory charter that AI cannot disintermediate. P/E ~14x, PEG ~0.51, and a step-up in NIM toward 4%+ by Q2-Q3 support modest upside to $36-41 if execution holds.

Bear case

The margin of safety is thin-to-absent. Multiple lenses (Klarman, Munger, Mauboussin) flag that the 0.98x reported P/B is deceptive — tangible book is only ~$19.11/share, so the stock trades at ~1.7x TBV, meaning ~40% of market cap rests on acquisition goodwill that evaporates in a stress scenario. Reported GAAP ROE is only ~7%, below the ~7.7-11% cost of equity — the valuation referee's excess-return model pegs warranted P/B at ~0.91x, implying the stock is ~9% overvalued on current (not projected) profitability. Q4 NIM was flattered by ~11 bps of one-time items; Q1 2026 guided down to 3.90-3.95%, creating an earnings step-down. The stock is at its 52-week high with a well-telegraphed, largely-priced-in synergy story, ~8.5x balance-sheet leverage, undisclosed CRE concentration, and a thin 1.02% ACL. Quality purists (Akre, Fisher, Smith, Greenblatt) abstained entirely — this is not a compounder.

Dissent — where the council disagrees

The sharpest split is between Greenwald/disruption-referee (both 72, Pass) and the valuation referee (58, Watch) plus the forensic short-seller (52). Greenwald sees EPV roughly equal to price with value-accretive buybacks; the valuation referee counters that at a 7% ROE below a ~7.7% cost of equity, growth is slightly VALUE-DESTRUCTIVE and buybacks at ~1.7x TBV may be dilutive — a view Mauboussin echoes. This matters because the entire bull case rests on ROTCE >17% being durable, but that figure is on tangible equity, cyclical, acquisition-driven, and inflated by one-time NIM items management itself flagged. Meanwhile all five hard-core quality/growth lenses (Akre, Fisher, Smith, Greenblatt) ABSTAINED, so there is no quality-compounder endorsement here at all — the 'passes' come from value/structural frameworks, not durability. The consensus of engaged lenses clusters tightly at 52-58 (Watch), and the two Passes are narrow and conditional. Every lens independently flagged the same data anomaly (revenue $177M vs. $550M net income, 43x P/S), reducing quantitative confidence.

Key risks

Q1 2026 systems-conversion execution risk — large bank integrations can surface hidden credit losses or customer attrition
NIM step-down (4.06% to guided 3.90-3.95%) with recovery to 4%+ dependent on macro-sensitive deposit normalization
Reported ROE ~7% below estimated cost of equity ~7.7% — growth may be value-destructive at current profitability
~8.5x balance-sheet leverage against undisclosed CRE/multifamily concentration and a thin 1.02% ACL
Stock at 52-week high with synergy catalyst largely priced in — no remaining re-rating trigger
~1.7x price-to-tangible-book means goodwill cushion is illusory in a credit downturn

Catalysts

Full $127M synergy run-rate realization by end Q2 2026
NIM recovery above 4% in Q2-Q3 2026 as deposit costs normalize
Clean PAC Premier systems conversion without attrition
$150-200M/quarter buybacks reducing share count
Deposit recovery in spring 2026 after seasonal Q1 outflows

DCF valuation

Not applicable: FCF-based DCF is not appropriate for Financial Services — banks/insurers are valued on P/B and ROE, REITs on P/FFO and cap rates.

Short-sell evaluation

🚫 AVOID SHORTING

COLB is a poor short despite thin valuation upside. The forensic short-seller (52) explicitly concluded this is 'not a compelling short' — the core earnings-vs-cash accrual test is favorable (OCF $746M > net income $550M, FCF $739M), the balance sheet is well-capitalized (CET1 11.8%), and the stock trades near book. A short would rely on Q1 NIM step-down or integration hiccups, but those are already disclosed and telegraphed. With a ~4.6% dividend yield, $150-200M/quarter buybacks, low beta (0.68), positive earnings momentum, and price at 52-week highs, the setup offers negative carry and asymmetric squeeze risk against real cash generation. The only credible bear angle is a broad regional-bank credit/CRE cycle turn — a macro bet, not a company-specific forensic short.

Pros (the short could work)

Reported ROE ~7% below estimated cost of equity; valuation referee sees ~9% downside to warranted P/B on current fundamentals
Q1 2026 NIM step-down to 3.90-3.95% and loss of ~11 bps one-time items create a visible earnings cliff
Heavy non-GAAP reliance (~$160M/yr CDI amortization stripped out) masks GAAP earnings weakness
~1.7x tangible book means goodwill-heavy balance sheet is vulnerable in a CRE/credit downturn with thin 1.02% ACL
Stock at 52-week high with synergy story fully priced in — limited upside, disappointment risk if conversion stumbles

Cons (what kills the short)

Strong cash generation (OCF and FCF both exceed net income) — no accrual red flag to exploit
Well-capitalized (CET1 11.8%) with positive earnings momentum (Q1 EPS +61% YoY) — hard fundamental floor
4.6% dividend yield plus $150-200M/quarter buybacks create meaningful negative carry and price support for a short
Trades near book (0.98x reported) — limited overvaluation cushion; not a stretched multiple to fade
Low beta (0.68) and constructive sentiment/momentum raise squeeze risk against unlimited downside
Forensic short-seller itself concluded this is not a compelling short — cash quality is real

Council scorecard

Lens	School	Stance	Score	Conf
Bruce Greenwald	value	🟢 pass	72	medium
AI & Disruption Referee (Christensen-style)	referee	🟢 pass	72	medium
Warren Buffett	quality	🟡 watch	58	medium
Valuation Referee (Damodaran-style)	referee	🟡 watch	58	medium
Benjamin Graham	value	🟡 watch	58	medium
Peter Lynch	growth	🟡 watch	58	medium
Howard Marks	risk	🟡 watch	55	medium
Michael Mauboussin	quality	🟡 watch	55	medium
Ray Dalio	risk	🟡 watch	52	medium
Stanley Druckenmiller	risk	🟡 watch	52	medium
Seth Klarman	value	🟡 watch	52	medium
Charlie Munger	quality	🟡 watch	52	medium
Walter Schloss	value	🟡 watch	52	medium
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟡 watch	52	medium
Chuck Akre	quality	⚪ abstain	—	high
Philip Fisher	growth	⚪ abstain	—	high
Joel Greenblatt	value	⚪ abstain	—	high
Terry Smith (Fundsmith)	quality	⚪ abstain	—	high

Member reasoning

Bruce Greenwald — 🟢 pass · 72/100 · medium confidence

Columbia Banking System is a regional bank, which creates methodological tension for a pure Greenwald EPV framework (banks are balance-sheet businesses where earnings power and asset reproduction value blur together). However, COLB is sufficiently mature and stable — with a real operating history, normalizable earnings, and identifiable scale advantages — that a modified EPV analysis is meaningful. I'll use P/B as the asset reproduction proxy and normalized earnings-to-equity as the EPV analog, consistent with Greenwald's own adaptations for financial firms.

Asset Reproduction Value: Book equity is $7.84B ($26.52/share at 295.6M shares). For a bank, tangible book is the most defensible reproduction floor. The stock trades at 0.98x book — essentially at reproduction cost. This is the Graham-style floor that value investors demand. Price-to-book below 1.0x is a classic Greenwald signal that you are not paying for any franchise premium above asset value.

Earnings Power Value: Normalized operating earnings: Net income of $550M in FY2025 includes integration-related noise from the Pacific Premier acquisition. Management guided operating EPS of ~$0.82/share in Q4 (annualized ~$3.28/share operating), implying operating net income of ~$970M annualized at scale with full $127M synergy realization. Even using the reported $550M (conservative, pre-synergy-run-rate FY2025), that yields ROE of ~7.0% — modestly below cost of equity (~9-10% for a regional bank). However, the Q1 2026 results showed EPS of $0.66 GAAP (+61% YoY) with $1.27B revenue (+38% YoY), and management's Q4 annualized run-rate with full synergies implies ~$1.2-1.4B normalized pre-tax PPNR. Using a conservative $800-900M sustainable net income (midpoint of 2025 actual plus synergy path, discounted for one-time NIM tailwinds), EPV on equity = $850M / ~10% cost of equity = ~$8.5B, or ~$28.75/share. This is modestly below current price of $32.15, suggesting the stock is approximately fairly valued with thin margin of safety.

Moat Assessment — EPV vs. Asset Value: EPV (~$28-30/share) is approximately equal to book value (~$26.52/share). This EPV ≈ asset reproduction value pattern is consistent with a competitively positioned but not deeply moated business — exactly what Greenwald expects from most regional banks. COLB does have real, if limited, barriers: (1) Pacific Northwest deposit franchise with strong commercial banking relationships built over decades; (2) post-PPB acquisition, top-10 deposit share in Southern California — meaningful scale within a geography; (3) customer captivity in treasury management and commercial relationships (high switching costs for business banking clients); (4) demonstrated deposit-gathering capability (three 2025 campaigns added $1.3B low-cost deposits). NIM of 4.06% vs. peer averages of ~3.5% suggests some pricing power. But these are 'good regional bank' advantages, not deep moats — competition is intense and deposit pricing is a constant threat.

One-Time Earnings Complexity: The Q4 NIM included $12M CD premium amortization and $5M accelerated loan repayment that won't repeat. Management guided Q1 2026 NIM down to 3.90-3.95%. This is exactly the kind of earnings normalization Greenwald demands — and the reported FY2025 $550M net income likely understates run-rate earnings (integration costs, one-time items pulling down), while Q4 annualized overestimates (NIM one-timers). True normalized earnings power sits in the $800-900M range, which supports a per-share EPV of ~$27-31. Current price of $32.15 is near the top of this range — thin but not absent margin of safety.

Capital Return & Buybacks: The aggressive buyback program ($150-200M/quarter) at ~0.98x book is genuinely value-accretive — buying below EPV and at book. This is the kind of capital allocation Greenwald approves of. Dividend of $0.37/quarter ($1.48 annualized) yields ~4.6% — a real yield floor.

Bottom line: COLB passes the Greenwald screen narrowly. It trades at or slightly below book (the asset reproduction floor), EPV is approximately equal to market price (thin margin of safety), the moat is real but limited (scale + customer captivity in commercial banking, not a franchise fortress), and management is deploying excess capital intelligently through buybacks at book. The main risk is that normalized earnings power is somewhat uncertain given acquisition integration noise, and the EPV/price gap is narrow. A 5-10% further pullback would make this a clearer pass; at current prices it's a modest pass for patient value investors comfortable with a thin margin of safety in a well-run franchise.

Key points

Stock trades at 0.98x book — at or below asset reproduction value, providing the Greenwald asset floor with no franchise premium required
EPV approximates ~$27-31/share using normalized $800-900M sustainable net income capitalized at ~10% cost of equity — stock near fair value with thin margin of safety
EPV ≈ Asset Value confirms limited but real moat: COLB has scale/customer captivity advantages in commercial banking, consistent with a competitively positioned regional bank rather than a deep franchise
Aggressive buybacks at ~book value ($150-200M/quarter) are value-accretive capital allocation — exactly what Greenwald applauds
Revenue CAGR of 27% over 3 years largely acquisition-driven (PPB); sustainable organic earnings power needs normalization from integration noise
NIM 4.06% vs. peer averages indicates some pricing power; $127M annualized synergy run-rate by Q2 2026 will be key to confirming normalized earnings
PEG of 0.51 and P/FCF of 10.36x suggest undemanding valuation relative to near-term earnings growth trajectory

Red flags

Q4 NIM included ~11 bps one-time tailwinds ($12M CD premium + $5M accelerated repayments) that will not recur — reported earnings overstate sustainable Q4 run-rate
FY2025 reported revenue of $177M in fundamentals block appears inconsistent with narrative citing $1.27B Q1 2026 revenue and $1.5B full-year operating expenses — data quality issue in fact base that clouds EPV normalization
Margin of safety is thin at current price (~$32): EPV range of $27-31/share offers only 0-15% upside buffer before growth assumptions are required
Integration execution risk: Q1 2026 systems conversion is the last major hurdle; large bank integrations historically carry tail risks that could impair earnings power
No deep identifiable moat — COLB's barriers (geography, commercial relationships) are real but replicable; EPV ≈ reproduction value confirms no durable franchise premium above asset value
Long-term debt shown as $0 in fundamentals (2011 period) — data staleness suggests fact base may be missing current debt structure, making full balance-sheet analysis incomplete

AI & Disruption Referee (Christensen-style) — 🟢 pass · 72/100 · medium confidence

Columbia Banking System (COLB) is a traditional regional bank — a business whose core economic function is balance-sheet intermediation (taking deposits, making loans, managing credit risk) and relationship-based banking services. Through the Christensen disruption lens, the central question is: can AI commoditize or disintermediate the core economic engine of COLB within 3-10 years? The answer is: partially yes on the edges (certain fee-based services, back-office operations, credit underwriting analytics), but the core deposit-gathering and lending franchise is structurally resistant to the classic disintermediation pattern for reasons that matter. Banks hold a regulatory license that is an extraordinary moat — no AI model or fintech can replicate federal deposit insurance, charter rights, or the trust infrastructure that backs fractional reserve banking without those same licenses and capital requirements. The 'job to be done' for COLB's core business is not matching/optimization that AI can replicate; it is risk-bearing capital allocation with regulatory sanction, plus relationship-driven commercial and SMB banking. That said, meaningful AI threats exist on the margins and must be named honestly. On the tailwind side: AI reduces COLB's own operating costs (fraud detection, KYC/AML automation, credit analytics, call center automation, document processing) — all of which compound operating leverage for incumbents with data. On the threat side: fintech lenders (SoFi, Upstart, LendingClub) use AI-native underwriting to price credit more granularly, potentially attracting COLB's better-quality borrowers who accept lower rates in exchange for speed; neobanks and embedded finance continue to erode the transactional deposit relationship for younger demographics; and large-cap banks (JPMorgan, BofA) with vastly superior AI investment budgets may develop consumer-facing AI tools that shrink the geographic stickiness advantage that regional banks like COLB depend on. The systems-conversion integration of Pacific Premier Bank (Q1 2026) is actually a data-layer consolidation event — if executed well, it creates a richer proprietary dataset across the combined balance sheet that makes AI-driven cross-sell and risk management more valuable, not less. COLB's ROE of ~7% (GAAP) and 17% ROTCE (operating) and NIM of 4%+ suggest it is not yet being commoditized on price — there is no visible take-rate compression in core banking yield. The biggest medium-term AI risk is in the fee income lines: treasury management automation, basic wealth/trust advisory, mortgage origination, and swap/syndication banking are all knowledge-work functions that AI is encroaching on — these represent $80-88M/quarter in fee revenue. If AI-native competitors or hyperscaler-embedded financial tools erode fee income meaningfully, COLB's multiple would compress. But this is not a core-revenue existential threat; it is a 10-20% fee income risk over 5-7 years, not a business-model obsolescence event. The falsifiable call: evidence of disruption would be NIM compression driven by AI-native lender competition taking prime commercial borrowers, deposit attrition to neobanks in the Pacific Northwest/Southern California footprint, or fee income decline in treasury/wealth lines. Evidence of non-disruption: continued margin expansion as AI tools reduce COLB's own OpEx (efficiency ratio improvement), growing proprietary data advantage post-PPB integration, and stable deposit retention through the 2026 retail campaign. Management does not discuss AI as a threat in any of the provided materials — this is a mild concern (management in partial denial of the fee-income disruption), but less damning than for a pure-play intermediary because the regulatory moat is not something management needs to 'defend' — it is structural. Overall: regional banking is one of the more AI-resilient business models in financial services due to charter barriers, relationship stickiness, and capital-bearing function, but COLB faces real margin erosion risk in fee services and long-run demographic pressure from digital-native banking alternatives.

Key points

Regulatory charter and deposit insurance are structural moats that no AI model or fintech can replicate without the same capital and licensing burden — the core balance-sheet intermediation function is not disintermediable by AI
AI is a cost tailwind for COLB: fraud/AML automation, credit analytics, document processing, and call-center AI all reduce non-interest expense, compounding the operating leverage already visible in the 2025 synergy program
Post-PPB integration creates a larger proprietary data set across $66B in assets — if AI tools are deployed against this data, the moat compounds rather than erodes
No visible take-rate or NIM compression attributable to AI-native competition as of reporting date; 4.06% Q4 NIM and stable credit quality signal no current displacement
Fee income (~$80-88M/quarter) in treasury, wealth/trust, mortgage origination, and syndication is the most AI-exposed segment — fintech and platform competitors are advancing here
AI-native lenders (Upstart, fintech platforms) represent a medium-term threat to prime commercial and consumer credit origination if COLB cannot match underwriting speed and granularity
Large-bank AI investment gap: JPMorgan and BofA are deploying billions in AI — COLB's competitive disadvantage in AI tooling vs. top-10 banks is a real but slow-moving risk over 5-10 years
The falsifiable call: NIM compression from AI-native lender competition OR fee income decline in treasury/wealth lines would confirm disruption; efficiency ratio improvement and stable deposit retention would disprove it

Red flags

Management makes zero mention of AI as a competitive threat in any available materials (earnings call, filings, narrative) — this is partial denial, though less alarming for a charter-protected business than for an unprotected intermediary
Fee income services (treasury management, wealth/trust advisory, mortgage, syndication) are knowledge-work functions where AI is compressing human expertise value — $80-88M/quarter at medium-term risk
Neobank and embedded finance competition for younger demographic deposit relationships in Pacific Northwest and Southern California could slowly erode the geographic stickiness that justifies COLB's regional premium
AI-native underwriting (Upstart-style) could selectively poach COLB's highest-quality commercial borrowers by offering faster approvals and marginally lower rates — adverse selection risk on the loan book over time
Large-bank AI infrastructure gap: COLB's technology investment is dwarfed by top-5 banks, creating a widening capability gap in AI-driven customer experience and risk management

Warren Buffett — 🟡 watch · 58/100 · medium confidence

Columbia Banking System is a regional bank — a business I understand well. Banks are inherently within my circle of competence when they are run conservatively, generate consistent returns, and avoid reckless leverage or complexity. COLB presents a mixed picture. On the positive side: P/B at 0.98x is modestly below book, ROE of ~7% is below my 15% threshold but management's own ROTCE guidance exceeds 17% on an operating basis (tangible basis adjusting for acquisition goodwill), NIM is expanding toward 4%+, credit quality is stable, capital ratios are solid (CET1 11.8%), and the dividend is growing with aggressive buybacks ($150-200M/quarter authorized). The Pacific Premier acquisition appears strategically sound — expanding western U.S. footprint and adding fee income streams. The Q4 2025 results were strong: PPNR +27% QoQ, revenue +47% YoY. However, several concerns prevent a full 'pass.' First, reported ROE of 7% is well below my 15% sustained threshold — this is partially an accounting artifact of acquisition goodwill, but goodwill is real economic cost. Second, the 'revenue' figure of $177M looks anomalous relative to $550M net income and $7.65B market cap — this data appears to reflect non-interest/fee revenue only, not total bank revenue, creating confusion in the price-to-sales ratio of 43x which is nonsensical for a bank. I must note this data quality issue. Third, the franchise moat is limited: regional banks compete on deposit pricing and relationship lending without meaningful network effects or brand pricing power — they are closer to commodity businesses than Coca-Cola or See's Candies. Fourth, the PAC Premier integration introduces execution risk; Q1 2026 systems conversion is the critical test. Fifth, NIM benefited from $17M in one-time items in Q4 that won't repeat. Sixth, the stock is trading at 52-week highs, suggesting the margin of safety is thin. The PEG of 0.51 and P/E of ~14x are reasonable but not compelling given the integration uncertainty and moat limitations. This is a well-run regional bank executing a sensible consolidation strategy, but it lacks the durable economic moat and high-ROE consistency I require for conviction.

Key points

P/B of 0.98x offers modest margin of safety vs book value — a classic bank valuation touchstone
Management-guided ROTCE >17% on operating/tangible basis is near my threshold, though reported GAAP ROE of 7% reflects acquisition goodwill drag
CET1 of 11.8% and total risk-based capital of 13.6% reflect conservative balance sheet management — banks survive by being conservative
Dividend raised to $0.37/share with $600M buyback authorization; $150-200M/quarter buyback pace signals management confidence and shareholder-friendly capital return
PAC Premier acquisition appears strategically rational — top-10 deposit share in Southern California, $127M synergy target 50% realized, full run-rate by Q2 2026
NIM expanding: 3.64% (Q4 2024) -> 3.84% (Q3 2025) -> 4.06% (Q4 2025), with structural trajectory toward 4%+ despite Q1 2026 guided dip to 3.90-3.95%
Credit quality remains stable: ACL 1.02% of loans, provisions modest at $23M, no deterioration despite macro uncertainty
3-year revenue CAGR of 27% driven by acquisitions, not purely organic — must assess normalized earnings power

Red flags

Regional bank moat is limited — no brand pricing power, network effects, or structural switching costs; competes largely on relationship lending and deposit pricing, resembling a commodity business more than an economic castle
Reported GAAP ROE of 7% is well below my 15% sustained threshold — even adjusting for goodwill, investors paid real economic cost for acquired assets
Q4 NIM included $17M in one-time benefits (CD premium amortization + accelerated loan repayment, ~11 bps) that management explicitly flagged will not recur — normalized earnings are lower
PAC Premier integration execution risk: systems conversion in Q1 2026 is the final major hurdle; large bank integrations historically carry tail risks including customer attrition and revenue disruption
Revenue data ($177M) appears to reflect only non-interest/fee income, making price-to-sales (43x) meaningless — total bank revenue (net interest income + non-interest income) is far larger; data quality issue limits full analysis
Stock trading at 52-week highs with zero margin below recent peak — limited margin of safety at current price despite modest discount to book
Transactional loan runoff of $2.8B portfolio creates near-term loan balance headwinds; replacement with higher-yield loans depends on origination capacity in a potentially slowing economy
Insider selling noted (EVP Devine sold 3,872 shares in June 2026) — minor but directionally worth noting

Valuation Referee (Damodaran-style) — 🟡 watch · 58/100 · medium confidence

Columbia Banking System is a regional bank, and the system-generated DCF correctly flags that FCF-based DCFF models are inappropriate for financial institutions. However, the Damodaran framework for banks uses an equity-cash-flow (dividend discount or excess-return) model rather than FCFF, and enough data exists to reverse-engineer implied expectations from observable metrics. The key valuation anchors for COLB are: P/B of 0.98x book ($7.84B equity, ~$26.52 tangible book per share vs. $32.15 price implying ~1.2x tangible book), P/E of 13.91x on FY2025 net income of $550M, and ROE of 7.02%. The Damodaran excess-return framework says intrinsic P/B = ROE/Cost of Equity (CoE). With a beta of 0.676, using a risk-free rate of ~4.3% and ERP of ~5%, CoE ≈ 4.3% + 0.676×5% = ~7.7%. At steady-state ROE of 7.02%, the warranted P/B = 7.02%/7.7% ≈ 0.91x book, implying intrinsic value around $29.30/share vs. current $32.15 — roughly 9% overvalued on a steady-state basis. The bull case requires ROE expansion to ~9–10%+ (management targets ROTCE >17%, but ROTCE is on tangible equity ~$5.6B vs. reported equity $7.84B, so reported ROE improvement path is more modest). The reported ROE of 7.02% is below the estimated CoE of ~7.7%, meaning at current profitability, growth is slightly value-destructive — every retained dollar earns less than the cost of equity. The path to value creation requires margin expansion: full synergy realization ($127M run-rate), NIM recovery to >4%, and operating leverage. If COLB achieves ROE of ~9–10% sustainably (plausible with synergies and NIM expansion per Q4 2025 call), warranted P/B rises to ~1.17–1.30x, implying $36–$41/share — reasonable upside. But this requires successful PAC Premier integration (Q1 2026 systems conversion is the critical execution gate), NIM recovering from Q1 dip back above 4%, and expense synergies fully captured by Q2 2026. The current price at 13.91x earnings and 0.98x reported book is not obviously cheap — it prices in most but not all of the improvement story. The PEG of 0.51 looks attractive but the 3-year revenue CAGR of 27.3% is heavily acquisition-distorted and not repeatable organically. Net income of $550M vs. market cap of $7.65B gives ~7.2% earnings yield, marginally above CoE. The stock sits at a narrow margin between 'fairly valued assuming successful execution' and 'modestly overvalued on current fundamentals.' Not enough margin of safety for a confident pass, but not a clear avoid either — a watch while monitoring Q1/Q2 2026 NIM and expense synergy execution.

Key points

Excess-return P/B model: at current ROE 7.02% vs. estimated CoE ~7.7%, warranted P/B ≈ 0.91x vs. current ~1.2x tangible book — stock is modestly above steady-state intrinsic value
Bull case P/B of 1.17–1.30x ($36–$41/share) is achievable IF ROE expands to 9–10% via full $127M synergy capture, NIM >4%, and operating leverage
Revenue CAGR of 27.3% is acquisition-distorted (PAC Premier); organic growth is much lower — do not use this as an organic growth rate in any forward model
P/E of 13.91x and earnings yield of ~7.2% are marginally above CoE, providing thin but non-zero value support at current fundamentals
Management's ROTCE >17% target is on tangible equity (~$5.6B); reported ROE on total equity ($7.84B) remains below CoE, making growth slightly value-dilutive until goodwill/intangibles amortize
NIM Q1 2026 guided 3.90–3.95% reflects loss of $17M one-time Q4 benefits — near-term earnings power is lower than Q4 run-rate; Q2+ recovery is critical to the thesis
$600M buyback authorization at or near book value is modestly accretive and provides return of capital support

Red flags

Current ROE (7.02%) < estimated CoE (~7.7%): on steady-state basis the stock appears modestly overvalued on a P/B excess-return framework
NIM one-time tailwinds (CD premium amortization, accelerated repayments) worth ~11 bps will not recur — Q1 2026 earnings power step-down is real
PAC Premier systems conversion in Q1 2026 is execution risk; integration-related customer/revenue attrition is not captured in current guidance
Revenue CAGR of 27.3% is M&A-driven and creates a misleading impression of organic growth runway; organic NIM and loan growth are the real drivers and are more modest
Long-term debt reported as $0 (2011 period) — data appears stale/missing; complete balance sheet picture including FHLB advances and subordinated debt is unclear from this fact base
P/S of 43.23x is distorted by bank revenue reporting conventions (net interest income as revenue) but signals the stock is not cheap on any normalized revenue basis
Minority insider selling (EVP Devine, 3,872 shares in June 2026) is a minor flag but directionally worth noting near 52-week highs

Benjamin Graham — 🟡 watch · 58/100 · medium confidence

Columbia Banking System is a legitimate, established regional bank with adequate size ($7.6B market cap, $66.8B total assets), a meaningful dividend record (recently raised to $0.37/share), and demonstrated profitability. However, applying Graham's framework to a bank requires adapted metrics — current ratio and working capital tests are not meaningful for deposit-funded institutions, so I focus on P/B, P/E, earnings stability, balance-sheet leverage, and dividend continuity. On the positive side: P/B of 0.98x is near par, below Graham's combined threshold (P/E x P/B = 13.91 x 0.98 = 13.6, well under 22.5); P/E of 13.91x is at — but not clearly below — Graham's 15x defensive ceiling; PEG of 0.51 suggests earnings growth is not fully priced; and the dividend has been paid and recently increased, meeting Graham's reliability standard. The ROE of 7.0% is modest but positive. However, several concerns temper enthusiasm: (1) The reported 'revenue' of $177M vs. net income of $550M and operating cash flow of $746M suggests accounting presentation anomalies in the fact base likely related to bank-specific revenue recognition — the price-to-sales of 43x is misleading and reflects total revenue (net interest income + non-interest income) being reported differently; management cites Q4 revenues of ~$1.27B annualized, implying the revenue figure in the fact base is incomplete. (2) Earnings quality depends heavily on the PAC Premier acquisition integration — one-time NIM boosts of 11 bps will not repeat, and synergy realization ($127M target) is only 50% complete. (3) Tangible book value is $19.11/share vs. price of $32.15, implying price-to-tangible-book of approximately 1.68x — meaningfully above book, which Graham would view cautiously, though total stockholders' equity-based P/B of 0.98x is acceptable if goodwill/intangibles are substantial post-acquisition. (4) Long-term debt is reported as zero, which for a bank is a structural feature (liabilities are predominantly customer deposits, ~$59B), not a sign of financial strength per se — leverage is extreme at ~8.5x equity. (5) Earnings history prior to the 2023 Umpqua merger and PAC Premier acquisition is not cleanly 10-year comparable — the entity has materially transformed, making Graham's stability test difficult to apply with confidence. (6) The stock is at its 52-week high, not being offered at a discount by a pessimistic Mr. Market. Net: modestly valued on earnings and book, dividend intact, adequate size — but insufficient margin of safety at current price (at/near 52-week high), uncertain earnings stability through integration, and tangible book discount is thin.

Key points

P/E of 13.91x sits just below Graham's 15x defensive ceiling — marginally acceptable but not cheap
P/B of 0.98x on equity book value passes combined P/E × P/B test (13.6 < 22.5)
Dividend raised to $0.37/share with uninterrupted payment history — satisfies Graham's reliability criterion
PEG of 0.51 suggests earnings growth not fully priced in
ROE of 7.0% is modest but positive; ROAA >1.4% and ROTCE >17% per management indicate operating quality
$127M synergy target 50% realized; full run-rate by Q2 2026 could boost earnings power
Stock at 52-week high — Mr. Market is optimistic, not pessimistic; Graham would wait for a better price

Red flags

Price at 52-week high ($32.15) with no margin of safety discount — Graham prefers buying from a pessimistic market
Tangible book value of ~$19.11/share implies price-to-tangible-book ~1.68x, providing thin asset-value cushion
Extreme bank leverage (~$59B deposits vs. $7.8B equity) is structural but demands high credit quality and stable funding
Earnings stability test compromised: entity materially transformed via Umpqua (2023) and PAC Premier (2025) mergers — no clean 10-year comparable earnings history
One-time NIM tailwinds (11 bps from CD premium + loan prepayment) will not repeat in 2026, creating Q1 earnings cliff
Revenue figure in fact base ($177M) appears inconsistent with reported quarterly revenues (~$1.27B Q1 2026) — data reliability concern
EVP insider selling (June 2026) is a minor but noted negative signal

Peter Lynch — 🟡 watch · 58/100 · medium confidence

Columbia Banking System is a regional bank stalwart/turnaround hybrid that I can understand in one sentence: a Pacific Northwest regional bank that acquired Pacific Premier Bank in 2024-2025 and is now harvesting integration synergies, margin expansion, and capital returns. The PEG of 0.51 is outstanding on its face — the best signal here — and I'd normally get very excited. But let me pressure-test it. The stated P/E is 13.91 and PEG 0.51 implies an earnings growth rate of roughly 27%. That growth rate is largely acquisition-driven (revenue CAGR 27% over 3 years), not organic unit-expansion. As a Lynch categorizer, this is a stalwart-with-acquisition-boost, not a fast grower. The merger-inflated revenue base means the 3-year CAGR is not repeatable — management itself guided Q1 2026 NIM down to 3.90-3.95% from a one-time-boosted 4.06%. Q4 NIM included $12M CD premium amortization and $5M accelerated loan repayment that won't repeat. So the earnings trajectory has a near-term cliff before synergies kick in fully. On valuation, P/B of 0.98x is genuinely cheap for a bank earning ROE of ~17% — that's the most compelling number in the fact base. P/E of ~14x on operating earnings is reasonable. The $0.37 quarterly dividend ($1.48 annualized) yields roughly 4.6% at $32.15, which is meaningful and was just raised. Yield-adjusted PEG is even better than 0.51. Balance sheet: debt-to-equity is reported at 0.0 (likely a data artifact for long-term debt from 2011), and total liabilities/equity ratio is 7.5x — which is normal for a bank but I always remind myself banks are structurally leveraged, so my usual 'strong balance sheet' test doesn't apply the same way. Capital ratios look solid: CET1 11.8%, total risk-based capital 13.6%. Cash $2.38B. The story I worry about: (1) PAC Premier acquisition is classic diworsification risk if the integration stumbles — management sounds confident but Q1 2026 systems conversion is the last big hurdle; (2) the earnings growth story depends heavily on $127M synergy realization, transactional loan replacement at 6.5%+ coupons, and deposit normalization — these are execution dependencies, not the repeatable 'cloning a store' formula I love in fast growers; (3) revenue of $177M shown in the fact base looks anomalously low against $1.27B Q1 2026 revenue run-rate reported in earnings — this is a data inconsistency that clouds my conviction (possibly full-year revenue is much higher and the $177M figure is a partial period or segment). The stock is at its 52-week high ($32.15), trading essentially at book value, with institutional interest building (TradingKey noting 'institutional confidence'). This is no longer a neglected stock — it's had an 'amazing run' with one long-term holder celebrating 100%+ returns. The buyback program ($150-200M/quarter) is shareholder-friendly and meaningful relative to $7.65B market cap. Overall: for a stalwart bank, P/B near 1x with 17% ROE and a sub-1 PEG is genuinely attractive, but the growth story is acquisition-driven and faces near-term NIM headwinds. This belongs in the 'watch' category — buy more on any Q1 2026 execution stumble that creates a dip, or confirm the synergy story fully materializes before committing at the 52-week high.

Key points

PEG of 0.51 is excellent on its face, and yield-adjusted PEG (adding ~4.6% dividend yield to growth) makes it even more attractive for a stalwart
P/B of 0.98x with ROE of 17% is a classic Lynch value signal — paying below book for a bank earning well above cost of equity
$0.37/quarter dividend ($1.48 annualized, ~4.6% yield) just raised 3%; income component is real and growing
CET1 11.8% and robust capital ratios give management flexibility to execute $150-200M/quarter buybacks — meaningful capital return
Three-year revenue CAGR of 27% driven by PAC Premier acquisition — understandable business with clear integration thesis
Q1 2026 EPS up 61% YoY shows tangible earnings momentum from merger synergies flowing through

Red flags

Earnings growth is acquisition-inflated, not organic unit-expansion — the 27% CAGR is not repeatable; this is a stalwart, not a fast grower, so PEG comparison must be adjusted
Q4 2025 NIM of 4.06% included $17M of one-time items (CD amortization + accelerated repayment); Q1 2026 guidance drops to 3.90-3.95%, creating near-term earnings deceleration optics
Systems conversion of PAC Premier scheduled Q1 2026 — large bank integrations carry real tail risk of customer attrition, system downtime, or revenue disruption that management cannot fully control
Revenue figure in fundamentals block ($177M) is inconsistent with Q1 2026 reported revenue of $1.27B — data quality issue that obscures true valuation picture
Stock is at 52-week high with institutional attention building; the 'neglected stock' edge is gone after a 100%+ run for long-term holders
Transactional loan runoff ($2.8B portfolio, 20-25% exiting) must be replaced with core 6.5%+ relationships in potentially slowing economy — execution risk, not guaranteed

Howard Marks — 🟡 watch · 55/100 · medium confidence

Columbia Banking System sits at an interesting juncture — not a classic distressed/out-of-favor buy, but not obviously overpriced either. The stock trades at 0.98x tangible book, P/E of ~13.9x, and price-to-FCF of ~10.4x, which are modest multiples for a bank that achieved ROAA >1.4% and ROTCE >17% in Q4 2025. The near-52-week high price ($32.15 vs. $32.70 high) and a 41% run from the 52-week low ($22.77) suggest the easy money has been made and sentiment has migrated from fearful to constructive-to-bullish. This is not a contrarian buy at current prices — the PAC Premier acquisition narrative is well-known, management tone is confident, retail longs are celebrating 100%+ returns, and options traders are positioning for $35-40. The crowd has already done much of the work. On the positive side: the balance sheet is not fragile — CET1 at 11.8%, ROTCE >17%, and the bank is generating substantial operating cash flow ($746M). Credit appears stable with ACL at 1.02% (1.32% including acquired loan discount), and the bank survived 2025 without credit blowups. Price-to-book just below 1x is not expensive for a bank earning mid-teens ROTCE. Key risks that concern me from a Marks perspective: (1) The NIM story has a one-time tailwind (11 bps from CD premium amortization + accelerated loan repayment) that will not repeat — Q1 2026 guidance of 3.90-3.95% is a meaningful step-down, and the recovery to 4%+ depends on deposit normalization assumptions that are macro-sensitive; (2) The $127M synergy realization story is almost fully priced in — 50% already captured, remainder by Q2 2026, leaving no future catalyst surprise; (3) Revenue figure of $177M vs. net income of $550M is anomalous and data appears inconsistent (likely GAAP revenue vs. total interest income discrepancy), making precise valuation uncertain — the $43x price-to-sales is clearly wrong for a bank and reflects data issues; (4) At near-52-week highs with bullish consensus, the embedded expectations are now 'average ER, but far better than peers' — the bar to disappoint is higher; (5) Transactional loan runoff ongoing, brokered deposit reduction, and Q1 seasonal outflows create legitimate Q1 2026 earnings noise that could disappoint price action even without fundamental deterioration. The asymmetry has narrowed significantly from the $22-25 range where margin of safety was more evident. This is not a name to avoid — the underlying bank is solid — but at current prices with optimism now priced in, it is a 'watch' rather than a 'pass.'

Key points

P/B ratio of 0.98x provides modest tangible asset coverage — not egregiously expensive for a bank earning ROTCE >17%, but the discount to book is thin
Q4 2025 NIM of 4.06% included ~11 bps of non-recurring items (CD premium amortization + accelerated repayment); Q1 2026 guided to 3.90-3.95%, creating near-term earnings deceleration risk
CET1 at 11.8% and total risk-based capital 13.6% indicate a well-capitalized, non-fragile balance sheet — surviving a moderate downturn is credible
Stock has run 41% off 52-week low to near 52-week high; retail sentiment bullish, long-term holders cashing out at 100%+ returns — sentiment has moved away from fear
PAC Premier synergy story ($127M target, 50% achieved) is well-telegraphed and will be fully realized by Q2 2026 — no remaining hidden catalyst in this narrative
P/E of 13.9x and price-to-FCF of 10.4x are not demanding for a mid-teen ROTCE bank, providing some floor valuation support
$600M buyback authorization with $150-200M/quarter commitment provides tangible capital return support to price; management demonstrably returning capital

Red flags

Near-52-week high price with bullish consensus — 'buying at the peak of popularity' risk; the contrarian window was at $22-25, not $32
NIM one-time tailwinds ($12M CD premium + $5M accelerated repayment) will not repeat in 2026 — Q1 guided 3.90-3.95% vs. 4.06% actual, and recovery to 4%+ is macro-dependent
Reported revenue figure ($177M) vs. net income ($550M) and operating cash flow ($746M) is internally inconsistent in the fact base, suggesting data anomalies that reduce confidence in precise valuation work
Transactional loan runoff ($2.8B portfolio, 20-25% expected exits) and seasonal deposit contraction in Q1 create tangible earnings noise risk in the near term
Synergy realization fully telegraphed and mostly complete — no remaining acquisition catalyst to drive re-rating; market now prices normalized earnings
EVP insider sale (3,872 shares, June 2026) at near-highs is a minor but directionally cautionary signal
Systems conversion for PAC Premier scheduled Q1 2026 — large integrations historically carry tail risks; if disrupted, could impair revenue/customer retention and invalidate NIM recovery narrative

Michael Mauboussin — 🟡 watch · 55/100 · medium confidence

Columbia Banking System (COLB) is assessable through the quality/expectations lens but presents a mixed picture. The core question is whether COLB earns a durable ROIC spread above its cost of equity, and whether the current price (~$32, P/B ~0.98x) implies expectations that are too low, fair, or too high. On ROE: reported ROE is 7.0% (2025), but management cites operating ROTCE >17% — a substantial gap driven by goodwill/intangibles from the umpire of acquisitions. The economic franchise must be judged at tangible capital where ROTCE of ~17% compares favorably against a cost of equity I'd estimate at 9-11% for a mid-large regional bank with beta 0.68. That spread is attractive if durable. However, this is a bank assembled via acquisition (including Pacific Premier), and the 17%+ ROTCE is partly cyclical (rate environment, NIM expansion) and partly acquisition-driven (synergies mid-realization). The NIM peaked at 4.06% in Q4 2025 with acknowledged one-time benefits (CD premium amortization, accelerated loan repayments totaling ~11 bps) that management explicitly flagged will not repeat. Q1 2026 NIM guided to 3.90-3.95% — a visible step-down. The moat analysis is the central difficulty: regional banking franchises have narrow-to-moderate moats at best. COLB's advantages are: (1) switching costs — commercial banking relationships are sticky due to treasury/cash management integration, lending history, personal relationships; this is real but not exceptional; (2) scale in specific Pacific Northwest and Southern California markets (top-10 deposit share post-PPB, though this is a market-level metric, not a structural barrier); (3) intangibles — culture and integration capability are cited (20+ conversions over 15 years), which is a genuine process advantage but not a durable moat in the Buffett sense. There are no network effects and no IP/regulatory exclusivity beyond standard banking licensing. Moat rating: Narrow, trajectory uncertain pending integration completion. On expectations: at P/B 0.98x and P/E ~14x, the market is pricing roughly book value — implying skepticism that ROTCE will be durably above cost of equity. If operating ROTCE of 17%+ is sustainable at normalized rates and full synergy realization, this valuation is conservative and embeds low expectations. The bull case hinges on: (a) NIM recovering to 4%+ by Q2-Q3 2026 as guided, (b) full $127M synergy realization by end Q2, (c) successful systems conversion without customer attrition, (d) transactional loan runoff successfully replaced at 6.5%+ yields. The bear case: NIM normalization is structural (not just one-time), synergy delays, credit deterioration in CRE (not yet visible but a tail risk), and deposit competition constraining spread. Distribution: ~25% probability bull (ROTCE stabilizes 15-17%, stock re-rates to 1.3-1.5x P/B, implying $35-45); ~45% base (ROTCE settles 11-13% post-rate normalization, P/B stays ~1x, stock in $28-35 range); ~30% bear (macro deterioration, credit losses, NIM compression, P/B dips to 0.7-0.8x, stock $18-24). Capital allocation is mixed: buybacks at $27 average in Q4 look disciplined (below book); $150-200M/quarter going forward at current $32 price is at/above tangible book (~$19.11/share implies TBV per share is well below price, so P/TBV is ~1.7x — buybacks here consume capital at a premium to tangible book, which is value-dilutive if ROTCE does not justify it). The EVP insider sale (3,872 shares) is immaterial. Revenue 'CAGR' of 27% over 3 years is M&A-driven, not organic, making the growth rate uninformative about competitive positioning. Overall: a reasonable franchise at an approximately fair price with meaningful execution uncertainty. Not a high-conviction quality compounder at current levels — expectations are roughly right, not clearly too low.

Key points

Operating ROTCE >17% vs estimated 9-11% cost of equity is an attractive spread IF durable — but Q4 NIM had 11 bps of non-recurring benefits explicitly flagged by management
P/B of 0.98x implies market doubts sustainable ROTCE above cost of equity; if 17% ROTCE is real and repeatable, the stock is cheap; if it normalizes to 11-13%, fair value is approximately right
Moat is Narrow: switching costs from commercial banking relationships and treasury management are real but not exceptional; no network effects, no IP, regional scale is limited
PAC Premier integration is the swing factor — $127M in synergies (50% realized), systems conversion Q1 2026; management execution track record is cited (20+ conversions) but this is the largest and most complex
Distribution of outcomes is wide: 25% bull ($35-45), 45% base ($28-35), 30% bear ($18-24) — embedded expectations roughly fair, not obviously mispriced
Buybacks at $150-200M/quarter at ~$32 price vs $19.11 TBV per share represent capital deployment at ~1.7x tangible book — value-neutral to value-dilutive depending on ROTCE sustainability

Red flags

NIM one-time benefits (CD premium + accelerated loan repayment = ~11 bps) explicitly will not repeat; Q1 2026 guided 10-15 bps lower — near-term earnings quality concern
Revenue CAGR of 27% is acquisition-driven, not organic; comps the organic growth signal and overstates competitive momentum
ROE of 7% vs operating ROTCE of 17% reveals substantial goodwill/intangible inflation from acquisitions — the stated book ROE understates capital consumption for economic analysis
Transactional loan runoff ($2.8B portfolio) requires successful replacement at higher-yielding relationships in a potentially slowing economy — execution risk unpriced in current guidance
CRE concentration post-PPB not fully disclosed in available materials; a key tail risk for credit quality is insufficiently visible in the fact base
Buybacks guided at $150-200M/quarter at prices above tangible book value (~$19.11/share) risk being value-dilutive if ROTCE normalizes below current elevated levels

Ray Dalio — 🟡 watch · 52/100 · medium confidence

Columbia Banking System (COLB) is quintessentially a macro/rate-cycle play — a regional bank whose economics are deeply embedded in the interest rate regime, the credit cycle, and regional economic health. This is exactly where my lens applies. The bank sits at the intersection of the long-term debt cycle (post-pandemic credit expansion, now normalizing), rate sensitivity (NIM is the core earnings driver), and balance sheet leverage (asset/equity ~8.5x). Positives: P/B at 0.98x signals no bubble-era premium; CET1 at 11.8% is solid regulatory capital; the PAC Premier integration brings geographic diversification across the western U.S. (CA, WA, OR, AZ, CO); management explicitly targets profitability over growth, consistent with cycle-aware discipline. The ROE of ~7% (GAAP basis) and ROTCE >17% reflect operating leverage being harvested post-acquisition. NIM expansion to 4.06% Q4 2025 looks strong but is partially one-time (CD premium amortization, $12M; accelerated loan repayments, $5M — 11 bps total) and guided to dip in Q1 2026. Critical concerns from my framework: (1) REGIME FRAGILITY — bank NIM expands in rising-rate/reflation environments but compresses sharply in falling-rate or deflationary bust scenarios; in stagflation, credit quality deteriorates while funding costs spike — the worst box for regional banks. COLB only works cleanly in 1.5 of 4 regimes (rising growth/moderate inflation being optimal). (2) DEBT CYCLE POSITION — the CRE construction runoff and transactional loan portfolio ($2.8B being deliberately allowed to amortize) are tell-tale signs of late-cycle caution, which is prudent, but the broader commercial real estate sector remains fragile; COLB's $47.8B loan book likely contains significant CRE exposure that hasn't yet fully repriced stress. ACL at 1.02% of loans (1.32% including credit discount) feels adequate for base case but thin for a severe credit contraction. (3) BALANCE SHEET LEVERAGE — with $66.8B assets and $7.8B equity, the leverage is inherent to banking; any meaningful deterioration in loan quality (NPAs rising from current stable levels) could erode tangible equity rapidly. Long-term debt figure shows $0 (likely mislabeled in data — FHLB borrowings and other structured funding would exist), but deposit funding dominance means wholesale/brokered deposit reliance is a key refinancing risk if market stress hits. (4) NIM DURATION RISK — the bank is asset-sensitive (benefits from higher rates), but in a sustained higher-for-longer regime, deposit costs continue repricing upward while loan repricing slows. The Q1 2026 NIM dip to 3.90-3.95% already signals this dynamic. A rapid rate-cutting cycle (deflationary bust scenario) would compress NIM further unless offset by loan growth. (5) GEOGRAPHIC CONCENTRATION — Pacific Northwest and Southern California are economically dynamic but concentrated; tech sector exposure (PNW) and commercial real estate (SoCal) could co-move in a tech/credit downturn. No international revenue diversification. (6) VALUATION — P/B near 1.0x and P/E 13.9x are not demanding, providing some cushion, but the stock has already run ~41% from its 52-week low ($22.77 to $32.15), so the margin-of-safety compression is real. PEG of 0.51 suggests earnings growth is not fully priced, which is a partial offset.

Key points

CET1 capital ratio of 11.8% provides regulatory buffer; P/B at 0.98x offers modest margin of safety against a credit-cycle deterioration scenario
NIM at 4.06% Q4 2025 benefited from ~11 bps of non-recurring items; guided to compress to 3.90-3.95% Q1 2026, confirming rate-cycle sensitivity and earnings volatility across regimes
PAC Premier integration adds western U.S. geographic spread (CA, WA, OR, AZ, CO) — incremental diversification within the same macro region, but not cross-cyclical or international
$127M annualized cost synergy target (50% realized) supports near-term earnings durability even if loan growth stalls — a partial buffer against cycle headwind
ACL at 1.02% loans (1.32% with credit discount) is adequate for benign conditions; $47.8B loan book with CRE and transactional multifamily exposure is the primary tail-risk lever in a credit contraction
Deposit base of $54.2B with seasonal outflows and brokered reduction ongoing — funding stability depends on economic confidence and retail deposit stickiness, both of which deteriorate in financial stress
$600M buyback authorization and $150-200M/quarter pace signals capital confidence but also means capital is being returned rather than built as a buffer against a potential cycle turn
Stock at 52-week high ($32.15), up ~41% from low — limited technical margin of safety even at sub-1x book

Red flags

Single-regime dependence: COLB earnings peak in rising-rate/moderate-growth environment; stagflation (rising rates + credit stress) and deflationary bust (falling rates + loan losses) both damage NIM and credit quality simultaneously — the bank has no natural hedge across all four macro quadrants
CRE concentration risk: large loan book ($47.8B) with significant commercial real estate exposure (CRE construction deliberately running off but existing stock remains); office and retail CRE vulnerable in prolonged economic softness
Q4 2025 NIM artificially elevated by $17M in one-time items (CD premium amortization + accelerated loan repayments); underlying NIM trajectory is more moderate, creating earnings cliff risk in Q1 2026 that could disappoint
Transactional loan runoff ($2.8B portfolio): 20-25% expected to exit; backfill dependent on new originations at 6.5%+ rates, which requires a benign credit demand environment — fragile in recession
Deposit concentration in Pacific Northwest/SoCal: these markets have outsized tech and commercial real estate exposure; correlated drawdown risk in a regional economic shock exceeds national average
No geographic or FX diversification of revenue: 100% U.S. Pacific Coast exposure means zero cushion against a regional economic shock or domestic credit event
Revenue metric anomaly: reported $177M 'revenue' with $550M net income implies GAAP revenue recognition issues or segment reporting quirks — the price-to-sales of 43x is nonsensical for a bank; this data inconsistency reduces confidence in cross-ratio analysis
Insider selling (EVP Devine sold 3,872 shares June 2026 at or near 52-week high) — minor but directionally concerning signal at peak valuation

Stanley Druckenmiller — 🟡 watch · 52/100 · medium confidence

COLB presents a mixed setup through a Druckenmiller lens. The earnings direction is genuinely inflecting upward — Q4 2025 PPNR +27% QoQ, net income +31% full-year, Q1 2026 EPS +61% YoY, NIM expanded 22 bps QoQ to 4.06%, and $127M synergy target tracking ahead of schedule. The PAC Premier integration is the primary catalyst, and synergy realization by end of Q2 2026 is a definable near-term earnings inflection point. However, the setup has critical flaws on my criteria. First, the NIM trajectory has a near-term headwind: Q4's 4.06% included $12M CD premium amortization and $5M accelerated loan repayment (totaling ~11 bps one-time) that will NOT repeat, guiding Q1 to 3.90–3.95% — a QoQ decline that creates earnings noise and removes the clean upward second derivative I need to size up. The inflection resumes in Q2–Q3 but this dip creates tape risk. Second, price action is ambiguous: the stock is at a 52-week high ($32.15) which technically confirms, but retail commentary shows frustration with the stock not tracking strong earnings beats and consolidation in the $29–$32 range for months. The stock is AT the high, not breaking away on volume. Third, the liquidity/Fed tailwind is present (rate cuts should benefit NIM repricing) but COLB is a regional bank with rate sensitivity cuts both ways — deposit repricing lag and competition could neutralize expected NIM expansion. Fourth, while the buyback program ($150–200M/quarter) is a mechanical earnings-per-share accelerant, it is not the kind of sector-leading macro wave I typically want behind a concentrated position. Regional banking is not a secular winner riding a dominant theme. Fifth, asymmetry is limited: P/B near 1.0x, P/E ~14x provides floor support, but upside to $40 (retail targets) requires flawless execution of synergies, NIM recovery, and continued loan growth — multiple things going right simultaneously. The thesis is investable but not large-position material until the Q1 NIM dip resolves and price confirms the resumption of the earnings inflection post-systems conversion.

Key points

Earnings inflecting strongly: Q1 2026 EPS +61% YoY, PPNR +27% QoQ in Q4 2025 — second derivative clearly positive on a trailing basis
PAC Premier synergy catalyst is real and near-term: $63M of $127M achieved, full run-rate by end Q2 2026 — a defined, dateable earnings step-up
NIM expansion story remains intact medium-term: management guides 4%+ return by Q2–Q3 2026 as deposit costs normalize and balance sheet optimization continues
Stock at 52-week highs ($32.15) — price technically confirms rather than fights the thesis
Buyback acceleration ($150–200M/quarter) is a strong mechanical EPS kicker reducing share count substantially
P/B ~0.98x and P/E ~14x provides value floor limiting downside; beta 0.68 means limited macro-driven drawdown risk

Red flags

Q1 2026 NIM guided DOWN to 3.90–3.95% from 4.06% — 11 bps one-time tailwinds reversing creates near-term earnings deceleration noise, the exact second-derivative turn I fear before sizing
Price consolidating in $29–32 range for months with retail frustration at stock not tracking beats — NOT the clean breakaway price confirmation I want before concentrating
Regional banking is not a secular winner thesis — no dominant macro or technology wave behind this; it's a well-executed acquisition story with a finite catalyst shelf life
Transactional loan runoff ($2.8B portfolio) and seasonal deposit contraction in Q1 create dual headwinds in the near quarter, muddying the forward earnings picture
Systems conversion in Q1 2026 is an execution risk event — large bank integrations historically surface surprises; if disruption materializes, the thesis timeline extends materially
EVP insider selling (3,872 shares, June 2026) is minor but directionally uninspiring at the stock's current high
No clear macro/sector rotation catalyst — regional banks broadly are not in leadership; no Fed inflection point or liquidity surge specifically favoring this name over large-cap financials

Seth Klarman — 🟡 watch · 52/100 · medium confidence

Columbia Banking System presents a mixed case through a Klarman-style lens. The most attractive feature is the price-to-book of 0.98x — essentially at tangible book value — which for a bank with a 17%+ ROTCE and 11.8% CET1 ratio suggests modest margin of safety on an asset-value basis. However, the margin of safety is thin rather than compelling: at ~$32/share against tangible book of ~$19.11/share (per management commentary), the stock trades at roughly 1.7x tangible book, which strips most of the asset-value cushion. The reported P/B of 0.98x appears to reference total book (including goodwill/intangibles from multiple acquisitions including PAC Premier), which a Klarman framework would heavily discount. A large regional bank built substantially through M&A carries significant intangible asset inflation — CDI amortization running ~$40M/quarter alone signals meaningful acquired intangibles on the balance sheet. Tangible book value of $19.11 vs. price of $32.15 implies ~1.68x P/TBV, which is not a distressed or deeply discounted entry point. On normalized earnings, P/E of 13.9x and price-to-FCF of 10.4x are reasonable but not the deep discounts Klarman demands. The PEG of 0.51 and 3-year revenue CAGR of 27% suggest the market is pricing in growth, not distress. The Q4 2025 NIM benefited from $17M in one-time items (11 bps) that will not repeat — normalized earnings power is somewhat lower than reported. ROE of 7.02% reported (fundamentals) appears understated vs. management's claimed >17% ROTCE, reflecting the goodwill-laden balance sheet. The PAC Premier integration represents a genuine complexity catalyst — if integration executes cleanly and the $127M synergy target is achieved, intrinsic value expands. However, this is a best-case scenario dependent on execution, not a hard downside-protected floor. The balance sheet shows $66.8B assets vs. $59B liabilities, with $7.8B equity — adequate regulatory capital but the loan book quality in a downturn (CRE exposure, transactional multifamily runoff) is not fully transparent in the available data. ACL at 1.02% (1.32% including acquired loan discounts) is thin if credit deteriorates materially. The dividend yield (~4.6% annualized at $0.37/quarter) provides some return floor, and the $600M buyback authorization at these prices is modestly value-accretive. The stock is at its 52-week high, which is the opposite of the forced-selling/orphaned-security dynamic Klarman seeks. No structural catalyst exists beyond continued integration execution — this is fundamentally a 'buy a good bank at a fair price' thesis, not a mispriced special situation with asymmetric downside protection.

Key points

Price trades at ~1.68x tangible book value ($32.15 vs. $19.11 TBV) — not a distressed asset-value entry; the reported 0.98x P/B includes goodwill/intangibles that should be discounted
CET1 of 11.8% and total risk-based capital of 13.6% provide regulatory buffer; $2.38B cash is adequate liquidity — balance sheet safety is reasonable but not exceptional
$127M annualized synergy target from PAC Premier acquisition is 50% achieved; if fully realized by Q2 2026, this is a genuine earnings catalyst but depends on execution
Dividend $0.37/quarter (~4.6% yield) and $150-200M/quarter buyback authorization provide meaningful capital return floor at current prices
P/E of 13.9x and P/FCF of 10.4x on normalized earnings are reasonable multiples but not the deep discounts Klarman requires — no compelling margin of safety
NIM contained one-time benefits of ~$17M (11 bps) in Q4 2025 that will not recur; Q1 2026 NIM guided 3.90-3.95%, creating near-term earnings headwind

Red flags

Stock is at 52-week high ($32.15 = 52w high) — antithetical to Klarman's opportunistic, distress-driven entry philosophy; no forced selling or technical mispricing evident
Tangible book of ~$19.11 vs. $32.15 price means 41% of market cap rests on goodwill/intangibles from acquisitions — this 'floor' is illusory in a stress scenario
Revenue reported as $177M while net income is $550M — data anomaly suggests revenue figure may be fee/noninterest income only, not net interest income; full revenue picture ($1.27B per Q1 2026 beat) obscures true margin analysis
Thesis depends on successful PAC Premier integration and synergy realization — this is an optimistic execution story, not a hard asset-backed margin of safety
ACL of 1.02% on a $47.8B loan book with meaningful CRE/construction exposure is thin; credit quality in a recession scenario not stress-tested in available data
EVP insider selling (3,872 shares, June 2026) at the 52-week high is a minor but notable negative signal at this price level

Charlie Munger — 🟡 watch · 52/100 · medium confidence

Columbia Banking System is a regional bank — a business I can largely understand, though banks are inherently more opaque than, say, a See's Candies or Coca-Cola. The leverage is embedded in the model, not a red flag per se, but it does limit my ability to assess quality with the same confidence I'd have in a simpler franchise. Here's my honest assessment:

On quality: ROE of ~7% (GAAP, book-basis) is weak by my standards — I want 15%+ on tangible equity consistently. Management cites ROTCE >17% on an operating basis, but that's an adjusted figure. Tangible book at $19.11/share vs. a $32 price means you're paying ~1.7x tangible book for a business that earns ~7% reported ROE on that elevated book. The NIM at 4.06% in Q4 2025 is respectable for a regional bank, but management explicitly disclosed that ~11 bps came from one-time items that will not repeat. That's honest disclosure — I credit management for transparency — but it means underlying earning power is somewhat less than headline Q4 suggests.

On the moat: Regional banks have limited moats. COLB has scale in the Pacific Northwest and is building Southern California presence via the Pacific Premier acquisition, giving it top-10 deposit share in SoCal. That's a real competitive position. Deposit franchises with sticky commercial relationships and low-cost core deposits are a modest moat. But it's not a wide moat — it's a decent franchise in a competitive, commoditized industry subject to interest rate cycles, credit cycles, and regulatory forces outside management's control.

On management quality: The PAC Premier acquisition and integration narrative is credible — 20+ conversions over 15 years, disciplined synergy tracking ($63M of $127M achieved on schedule), candid NIM guidance including the one-time cliff. CEO Stein's 'profitability over growth for growth's sake' framing is Munger-friendly. The $150-200M/quarter buyback commitment at ~1.7x tangible book is reasonable capital allocation given excess capital. Dividend increased modestly. No obvious empire-building or promotional behavior. This is above-average management for a regional bank.

On accounting and balance sheet: The revenue figure ($177M reported) vs. net income ($550M) relationship looks anomalous — this is almost certainly a GAAP presentation artifact where net interest income is not captured in 'revenue' as reported in the fundamentals block. Operating cash flow of $746M and FCF of $739M are strong relative to the ~$7.65B market cap, implying a ~9.7% owner earnings yield — that's genuinely attractive if sustainable. P/B of 0.98x is at tangible book on a reported basis, suggesting the market is skeptical of the goodwill/intangible-laden book value. CET1 of 11.8% is solid.

On price: P/E of 13.9x, price-to-FCF of 10.4x, PEG of 0.51 — these are not expensive multiples for a well-run regional bank. At ~1.7x tangible book with ROTCE >17% (operating), the stock is arguably fairly priced. The DCF is appropriately flagged as not applicable for a bank. My concern is that the 'operating' ROTCE relies on adjusted earnings; reported ROE of 7% against a 0.98x P/B multiple means you're not getting a bargain on a reported basis either.

Inversion test: What destroys this? A credit cycle turning the CRE and commercial loan book — especially with $47.8B in gross loans against $7.8B equity — would rapidly impair book value. Pacific Premier integration failures. Deposit flight. Rate cuts compressing NIM back toward 3.5%. None of these is imminent, but none is implausible in a recession. The leverage inherent in banking (total assets $66.8B vs. equity $7.8B — roughly 8.5x leverage) means small asset quality deterioration hits equity hard.

Bottom line: This is a better-than-average regional bank, well-managed, with a credible integration story and reasonable capital return program. But it lacks the durable, wide moat and high-confidence compounding I require for a 'pass.' I'd watch it — monitor whether the ROTCE story holds post-integration, whether NIM actually recovers to 4%+ in Q2-Q3 2026 as guided, and whether credit stays clean through the cycle. Not a cigar butt, not a wonderful business — a good business at a fair price, which puts it squarely in 'watch' territory.

Key points

Operating ROTCE >17% is attractive if real; reported ROE ~7% is less impressive — the gap between adjusted and GAAP metrics warrants scrutiny
P/E ~14x and price-to-FCF ~10x are reasonable multiples; 0.98x P/B is not a screaming bargain given goodwill/intangibles from acquisitions
Management track record on integration (20+ conversions, candid guidance, synergy delivery on schedule) is above average for a regional bank — owner-minded tone
Pacific Premier acquisition adds SoCal scale and top-10 deposit share — a modest but real competitive enhancement to franchise value
$150-200M/quarter buyback authorization at current prices is sensible capital allocation, supporting per-share value growth
Deposit franchise with sticky commercial relationships and fee businesses (treasury, wealth, international) provides modest moat above pure commodity banking
Q1 2026 NIM cliff (-11 bps from one-time items) is fully disclosed; management projects recovery to >4% by Q2-Q3 — a testable claim

Red flags

Banking is inherently leveraged (~8.5x assets to equity) — small credit deterioration in $47.8B loan book can rapidly impair tangible equity; this is the primary inversion risk
NIM benefited ~11 bps from non-recurring items in Q4 2025; underlying earning power is lower than headline suggests and Q1 2026 will show the real run-rate
Revenue figure in fundamentals block ($177M) appears anomalous relative to $550M net income — data quality issue that prevents clean quantitative assessment; cross-referencing required
Goodwill and intangibles from PAC Premier acquisition inflate reported book value; reported P/B of 0.98x may overstate the tangible asset coverage
Regional banks lack durable pricing power or network effects — NIM is ultimately a commodity spread subject to rate cycles and deposit competition outside management's control
No circle-of-competence confidence that I can predict earning power 10 years out with high conviction — the rate cycle, regulatory environment, and credit cycle make this harder to underwrite than a consumer franchise
Insider selling (EVP Devine, 3,872 shares) is minor but noted; no significant insider buying to signal strong conviction at current prices

Walter Schloss — 🟡 watch · 52/100 · medium confidence

Columbia Banking System presents a mixed picture through a Schloss value lens. On the positive side, the stock trades near tangible book value (P/B of 0.98x — essentially at book, which is the Schloss sweet spot for banks) and pays a rising dividend ($0.37/share, recently increased). The 52-week range shows the stock has recovered from $22.77 to $32.15 — meaning it is now at its 52-week HIGH, not a low, which is the opposite of what Schloss preferred. He bought beaten-down, out-of-favor names, not stocks at their highs. The balance sheet is a bank balance sheet: total assets $66.8B, stockholders' equity $7.84B, giving a tangible asset base, but also $59B in liabilities — extreme leverage by any industrial standard (debt-to-equity of ~7.5x when you look at total liabilities/equity, even though reported 'long-term debt' shows $0, which appears to be a data anomaly reflecting that bank deposits and borrowings are classified differently). This leverage is intrinsic to banking and not a red flag per se for the sector, but Schloss fundamentally preferred low-leverage businesses. The ROE of 7.02% is modest, meaning earnings power relative to book is not compelling enough to argue for a premium. The P/E of 13.9x and price-to-FCF of 10.4x are reasonable but not deep-value cheap. The revenue figure of $177M appears to reflect only non-interest income (net interest income appears excluded from this measure), making the price-to-sales of 43x misleading — this is a bank and total revenues (NII + non-interest) are far higher, consistent with the Q4 2025 reports showing ~$1.27B quarterly revenue. Critical missing data: insider ownership percentage is not disclosed in the fact base; the only insider transaction noted is an EVP selling 3,872 shares (minor but directionally negative for a Schloss screen). The acquisition of Pacific Premier Bank adds goodwill and integration complexity that makes the balance sheet harder to appraise on tangible-asset terms — Schloss avoided complexity and M&A-inflated book values. The thesis depends heavily on NIM recovery, synergy realization, and integration execution — all forward-looking narrative, not hard assets. The stock being at its 52-week high is the single biggest Schloss disqualifier here; he would wait for a meaningful pullback toward or below book before engaging. At current price (~1x book), there is no margin of safety embedded in the asset discount. A pull to $22-25 range (0.7-0.8x book) would be more interesting.

Key points

P/B of 0.98x is near book value — the closest thing to a Schloss valuation anchor for a bank, but no discount is present
Stock is AT its 52-week high ($32.15), the opposite of the beaten-down, out-of-favor positioning Schloss required
Rising dividend ($0.37/share, recently raised) signals balance-sheet durability and rewards patient holders — a genuine positive
Total liabilities of $59B against $7.84B equity reflects inherent bank leverage (~7.5x L/E); not a flaw for the sector but alien to Schloss's low-debt preference
Revenue data ($177M) appears to capture only fee income, not total bank revenues; the business is far larger than the ratio implies
ROE of 7.02% is below Schloss's ideal — not a high-return business compounding book value rapidly

Red flags

Stock is at 52-week high, not near a multi-year low — Schloss bought deeply out of favor, not at highs
Pacific Premier acquisition adds goodwill, integration complexity, and forward-looking synergy assumptions that obscure true tangible book value — Schloss avoided complexity and acquisition-inflated balance sheets
EVP insider selling noted (3,872 shares) with no offsetting buying disclosed — insider alignment unclear
Thesis depends on NIM recovery, deposit normalization, and integration execution — narrative-driven, not asset-driven margin of safety
Insider ownership data not available in fact base — cannot confirm alignment with outside shareholders
Operating margin data missing; the 3.1% net margin figure and revenue anomaly make earnings quality harder to verify from provided data alone

Forensic Short-Seller (Chanos/Einhorn-style) — 🟡 watch · 52/100 · medium confidence

COLB is a regional bank, which limits the applicability of standard forensic short-selling tests (DSO, inventory, capitalized costs, SBC-driven dilution) since banks are fundamentally different entities. However, enough SEC filing and earnings call data exist to run the key applicable tests: earnings vs. cash quality, non-GAAP reliance, insider activity, M&A integration opacity, and balance sheet leverage. On the core earnings-vs-cash test, the data is actually favorable — operating cash flow ($746M) materially exceeds net income ($550M), and FCF ($739M) is robust, suggesting earnings are backed by cash and there is no classic accrual red flag. The P/B of 0.98x is modestly below book, providing some margin. However, several forensic concerns warrant a 'watch' rather than a clean pass: (1) The heavy non-GAAP reliance is evident — management's preferred metrics are 'operating PPNR,' 'operating net income,' and 'operating EPS,' all excluding CDI amortization (~$40M/quarter) and integration charges. This is a $160M+ annual expense being stripped from the headline number. GAAP EPS ($0.66 Q1 2026) vs. operating EPS ($0.82 Q4 2025) divergence is meaningful. (2) The PAC Premier acquisition creates classic serial-acquirer forensic risk: purchase accounting noise (CD premium amortization, acquired loan credit discounts), synergy targets that management controls the timeline on, and a systems conversion that could surface hidden credit or operational problems. The $127M synergy target conveniently arrives 'by end of Q2' — impossible to independently verify yet. (3) NIM 'quality' is suspect: Q4 2025 NIM of 4.06% included $12M CD premium amortization (11 bps) and $5M accelerated loan repayment — management disclosed these won't repeat, meaning reported Q4 profitability was flattered by one-time items while the operating EPS metric still excluded them. This is a double layer of flattery. (4) Insider selling: EVP Devine sold 3,872 shares in June 2026 — modest but directionally noted; no cluster of large insider sales flagged, so this is a yellow flag, not red. (5) Revenue figure anomaly: reported revenue of $177M for fiscal 2025 vs. Q1 2026 revenue of $1.27B annualized implies a data quality issue in the fundamentals block — price-to-sales of 43.23x is almost certainly wrong for a bank this size (total assets $66.8B). This data inconsistency makes precise forensic analysis harder and reduces confidence. (6) Loan portfolio runoff: $47.8B gross loans declining, with intentional runoff of below-market transactional loans. If the economy weakens, the assumption that 75-80% of transactional multifamily loans are retained at 6.5-7% coupons becomes optimistic, and credit losses could surface faster than the ACL of 1.02% (1.32% including acquired discount) implies. (7) Capital structure: debt-to-equity reported as 0.0 (likely a data error — banks have implicit leverage of ~8:1 through deposits; total liabilities $59B vs. equity $7.8B). The bank is not financing-dependent in a traditional corporate sense but is highly deposit-dependent. The kill question for a forensic bear thesis would be: does systems conversion surface hidden credit losses or customer attrition, do synergy savings fail to materialize by Q2 end causing expense guidance misses, and does NIM fail to recover to 4%+ in Q2-Q3 as guided — any one of these would catalyze a meaningful re-rating. The disproof: NIM recovery on track by Q3, GAAP earnings converge toward operating metrics as integration charges roll off, and credit losses remain below 1% of loans. This is not a compelling short — the cash generation is real — but the non-GAAP opacity, acquisition accounting complexity, and NIM quality issues justify forensic vigilance.

Key points

Operating cash flow ($746M) exceeds net income ($550M), passing the core earnings-vs-cash accrual test — no classic Chanos red flag here
Non-GAAP reliance is heavy: CDI amortization (~$40M/quarter = $160M+ annually) and integration charges excluded from 'operating' metrics; GAAP EPS ($0.66 Q1 2026) diverges materially from operating EPS
Q4 2025 NIM of 4.06% was flattered by $12M CD premium amortization (11 bps) + $5M accelerated repayment — both one-time; Q1 2026 guided to 3.90-3.95%, a disclosed quality-of-earnings issue
PAC Premier acquisition creates serial-acquirer opacity: $127M synergy target managed by insiders, purchase accounting noise, and a Q1 2026 systems conversion that is the key execution test
Loan portfolio intentionally shrinking ($47.8B from $48.5B); credit quality benign at 1.02% ACL but relies on deposit retention and refilling with higher-coupon loans in a potentially weakening economy
Revenue figure in fundamentals ($177M for FY2025) appears erroneous for a $67B asset bank — reduces confidence in data-driven forensic ratios; P/S of 43x is almost certainly a data artifact

Red flags

Heavy non-GAAP metric reliance with $160M+ annual CDI amortization excluded — a real economic cost of M&A that management perpetually strips out
NIM quality: Q4 headline margins included acknowledged one-time items that management separately excluded from 'operating' metrics, creating a double-layer of favorable presentation
Insider selling by EVP Devine (3,872 shares, June 2026) — modest but directionally negative signal post strong run
Fundamentals data anomaly (revenue $177M implies 43x P/S for a $67B bank) — suggests data integrity issue that limits forensic precision
Acquisition execution risk: Q1 2026 systems conversion could surface hidden credit, customer attrition, or operational losses not yet visible in reported metrics
Deposit dependence: $54B in customer deposits with intentional brokered deposit reduction and seasonal Q1 outflows — any deposit flight scenario would be severe given 8:1 implicit leverage

Chuck Akre — abstained

Columbia Banking System is a regional bank — precisely the category I explicitly set aside. Banks are balance-sheet-driven businesses where ROE is structurally dependent on leverage (COLB has ~$59B in liabilities against ~$7.8B equity, roughly 7.5x leverage), capital intensity is embedded in the regulated balance sheet, and 'free cash flow' is a misleading concept because retained earnings must be held as regulatory capital rather than freely redeployed. The three-legged stool framework does not translate: (1) the 'extraordinary business' test requires capital-light franchise economics — a bank's spread-lending model is capital-heavy and cyclically sensitive; (2) reinvestment runway is constrained by regulatory capital requirements and deposit competition, not by addressable market logic; (3) what looks like ROE (~7% reported, far below my 20%+ bar even before adjusting for leverage) is an accounting artifact of the regulated model, not a signal of genuine economic returns on owners' capital. The FCF-based DCF is flagged not-applicable by the valuation block for the same reasons. COLB may be a fine bank on bank metrics (P/B ~0.98, P/E ~14, dividend growth, post-merger integration), but it is not the type of compounding franchise machine I invest in. I abstain with high confidence — this is not a stretch call, it is a structural mismatch.

Key points

Bank balance sheets are inherently leveraged (~7.5x here); ROE of ~7% is not a genuine capital-light return
FCF-based compounding framework does not apply to regulated financial institutions
Reinvestment runway is constrained by capital regulations, not by market opportunity
No capital-light franchise moat — spread lending is a commodity business subject to rate cycles and deposit competition
My style is explicitly inapplicable to banks, insurers, and balance-sheet-driven businesses

Red flags

Leverage-driven ROE is my primary disqualifier — COLB's equity is ~12% of total assets
Revenue figure of $177M against $7.6B market cap implies either a data anomaly or non-standard revenue recognition for banks — further evidence the standard metrics do not apply here
Long-term debt shown as $0 (2011 period) suggests stale/incomplete data in the fact base, reducing confidence in any quantitative assessment

Philip Fisher — abstained

Columbia Banking System is a regional commercial bank — a financial intermediary business, not a product/R&D-driven growth company. My investment framework is explicitly designed for companies that compound value through proprietary products, meaningful R&D, expanding addressable markets, and a durable technological or marketing edge. Banks grow earnings primarily through net interest margin management, credit underwriting discipline, deposit gathering, and balance sheet scale — none of which map to my scuttlebutt criteria, product pipeline analysis, or R&D-to-revenue conversion assessment. COLB's 'growth' is almost entirely acquisition-driven (Pacific Premier Bank merger) rather than organic product or market expansion. Revenue CAGR of 27% over 3 years is a statistical artifact of M&A, not the kind of compounding organic volume growth I seek. There is no R&D spend to evaluate, no product pipeline, no new market penetration in the Fisher sense. Forcing my framework onto a rate-sensitive, regulated balance-sheet business would produce a meaningless verdict.

Key points

Business model is financial intermediation, not product/R&D innovation — my framework does not apply
Revenue CAGR of ~27% is M&A-driven (Pacific Premier acquisition), not organic volume/product growth
No R&D spend or product pipeline exists to evaluate against my core criteria
Margin analysis in banking (NIM, efficiency ratio) differs categorically from industrial/tech gross/operating margin analysis
Management quality and candor criteria could theoretically apply, but insufficient to justify engagement without the growth engine I require

Red flags

Growth is explicitly acquisition-driven — the precise 'bought rather than earned' pattern I flag as a disqualifier
No organic sales growth runway identifiable — loan/deposit volumes are flat to declining post-merger as management intentionally runs off transactional loans
Zero R&D investment reported — cannot assess future product pipeline
Business is highly rate-sensitive and cyclical in earnings, not the durable compounding franchise I seek

Joel Greenblatt — abstained

Columbia Banking System is a regional bank — precisely the category I explicitly exclude from the Magic Formula framework. Banks and financial institutions have capital structures where EBIT and invested capital are not meaningful or reliably derivable. For a bank, 'debt' is a raw material (deposits are funding, not leverage in the traditional sense), net working capital and net fixed assets are not the operative capital base, and EV calculations become circular because financial liabilities cannot be cleanly separated from operating liabilities. The valuation block in the fact base itself flags this: 'FCF-based DCF is not appropriate for Financial Services — banks/insurers are valued on P/B and ROE.' The same logic applies to my EBIT/IC and EBIT/EV framework. I cannot construct a reliable earnings yield or ROIC number for COLB that would be comparable to non-financial businesses, so any Magic Formula ranking would be meaningless. Abstaining is the intellectually honest call — not a judgment on the business quality, but a recognition that my tools do not apply here.

Key points

Banks are explicitly excluded from Greenblatt's Magic Formula — deposits are raw material not debt, so EV is undefinable
EBIT/IC is unmeasurable for banks: no clean separation of operating vs. financing capital
The fact base's own valuation block flags financial services as incompatible with standard valuation frameworks
Reported ROE of 7.0% and P/B of 0.98x are the correct metrics for a bank — but those are not my framework's metrics
Engaging anyway would require stretching my framework beyond its design limits, producing a spurious score

Red flags

Financial institution — fundamental incompatibility with Magic Formula ROIC/earnings yield methodology
No reliable EBIT figure derivable from bank income statements (net interest income ≠ operating EBIT)
EV calculation circular for banks where liabilities are funding instruments
Revenue figure of $177M vs. net income of $550M and assets of $66.8B signals the data oddities typical of bank financial reporting that make my inputs unreliable

Terry Smith (Fundsmith) — abstained

Columbia Banking System is a regional bank — precisely the capital-intensive, low-return-on-equity, balance-sheet-heavy sector that Terry Smith explicitly excludes from Fundsmith's investable universe. Banks are financial intermediaries whose economics are structurally incompatible with Fundsmith's quality screen: (1) ROCE is not a meaningful metric — the 'capital employed' concept does not apply cleanly to a leveraged deposit-taking institution; (2) the business model is inherently capital-intensive in the financial sense, with $66.8B in total assets funded by $59B in liabilities (88% leverage ratio); (3) returns depend heavily on the interest rate cycle and credit cycle, not durable pricing power or an economic moat in the consumer/B2B sense Smith looks for; (4) growth has been driven by serial, debt-funded acquisitions (most recently Pacific Premier Bank), with large goodwill/intangibles on the balance sheet — a specific red flag in Smith's framework; (5) the 'revenue' figure of $177M appears anomalous relative to reported net income of $550M and total assets of $66.8B, suggesting the fundamentals block is capturing net interest income or some partial figure, underscoring that standard P&L metrics do not map cleanly to bank economics. The valuation block itself flags DCF as not applicable. There is no analytical basis for applying Fundsmith's ROCE, gross margin, cash conversion, or capital-intensity screens to a regional bank, and doing so would produce meaningless numbers. Smith has been consistently explicit: banks are not Fundsmith businesses.

Key points

Regional bank — structurally excluded from Fundsmith's investable universe
ROCE framework inapplicable to leveraged deposit-taking institution with 88% liability-to-asset ratio
Growth driven by serial acquisitions (Umpqua 2023, Pacific Premier 2025) — explicit Fundsmith red flag
No durable pricing power moat of the type Smith requires (brands, network effects, switching costs, essential consumables)
Interest rate and credit cycle dependency makes earnings inherently volatile, not the 'resilient, predictable demand' Smith requires
Valuation block itself flags DCF inapplicable for financial services — consistent with abstain judgment

Red flags

Serial debt-funded acquisitions with large goodwill and adjusted earnings metrics (operating vs GAAP EPS divergence cited throughout)
Extreme financial leverage ($58.9B liabilities vs $7.8B equity) — antithetical to Smith's low-leverage preference
Earnings quality questionable: reported revenue $177M yet net income $550M — data anomaly suggests non-standard financial structure incompatible with standard quality screens
Capital-intensive financial sector with thin and cyclical returns — ROE of 7.0% is well below Smith's 20%+ ROCE threshold
NIM benefits in Q4 2025 explicitly non-recurring — earnings quality concern even within bank-specific framing

Fact base appendix

Price

last_close: 32.15
as_of: 2026-06-27
high_52w: 32.15
low_52w: 32.15
pct_below_52w_high: 0.0

Fundamentals

last_price: 32.15
market_cap: 7652390389
fifty_two_week_low: 22.77
fifty_two_week_high: 32.7
beta: 0.676
change_pct: 0.24945
currency: USD
sector: Financial Services
industry: Banks - Regional
price_source: fmp_profile
bars: 1
entity: COLUMBIA BANKING SYSTEM, INC.
fiscal_year: 2025
revenue: 177000000
revenue_period: 2025-12-31
net_income: 550000000
net_income_period: 2025-12-31
operating_cash_flow: 746000000
operating_cash_flow_period: 2025-12-31
capex: 7210000
capex_period: 2022-12-31
total_assets: 66832000000
total_assets_period: 2025-12-31
total_liabilities: 58992000000
total_liabilities_period: 2025-12-31
stockholders_equity: 7840000000
stockholders_equity_period: 2025-12-31
cash_and_equivalents: 2380000000
cash_and_equivalents_period: 2025-12-31
long_term_debt: 0
long_term_debt_period: 2011-12-31
shares_outstanding: 295550687
operating_margin: None
net_margin: 3.1073
roe: 0.0702
debt_to_equity: 0.0
current_ratio: None
free_cash_flow: 738790000
fcf_margin: 4.174
pe_ratio: 13.91
price_to_fcf: 10.36
price_to_sales: 43.23
revenue_cagr: 0.2729
revenue_cagr_years: 3
fundamentals_source: edgar_companyfacts
price_to_book: 0.98
peg: 0.51

Filings reviewed

8-K (2026-05-15) https://www.sec.gov/Archives/edgar/data/887343/000088734326000143/colb-20260515.htm
8-K (2026-05-15) https://www.sec.gov/Archives/edgar/data/887343/000088734326000142/colb-20260514.htm
10-Q (2026-05-05) https://www.sec.gov/Archives/edgar/data/887343/000088734326000135/colb-20260331.htm
10-K (2026-02-26) https://www.sec.gov/Archives/edgar/data/887343/000088734326000088/colb-20251231.htm
10-Q (2025-11-06) https://www.sec.gov/Archives/edgar/data/887343/000088734325000268/colb-20250930.htm
10-K (2025-02-25) https://www.sec.gov/Archives/edgar/data/887343/000088734325000054/colb-20241231.htm

Other sources

[news] Columbia Banking (NASDAQ: COLB) EVP Devine sells 3,872 common shares - Stock Titan
[news] Columbia Banking System And 2 More Top Dividend Stocks To Consider - simplywall.st
[news] Columbia Banking System Inc (COLB) Institutional Confidence - TradingKey
[news] Columbia Banking (COLB) director receives grant of deferred phantom stock units - Stock Titan
[news] COLUMBIA BANKING SYSTEM, INC. REPORTS THIRD QUARTER 2025 RESULTS - PR Newswire
[news] Columbia Banking System And 2 Other Leading Dividend Stocks - Yahoo Finance
[news] Columbia Banking System, Inc. Actuals & Estimates (NASDAQ:COLB) - TradingView
[news] COLB Forecast — Price Target — Prediction for 2027 - TradingView
[news] COLUMBIA BANKING SYSTEM, INC. REPORTS FIRST QUARTER 2026 RESULTS - PR Newswire
[news] COLUMBIA BANKING SYSTEM, INC. REPORTS FOURTH QUARTER 2025 RESULTS - PR Newswire
[news] Is Columbia Banking System, Inc. (COLB) A Good Stock To Buy Now? - Yahoo Finance
[news] CM6 Forecast — Price Target — Prediction for 2027 - TradingView
[news] COLB News | COLUMBIA BANKING SYSTEM INC (NASDAQ:COLB) - ChartMill
[news] Columbia Banking System Announces $0.37 Per Common Share Dividend - PR Newswire
[news] Columbia Banking System Announces Increase to Common Share Dividend - PR Newswire
[discussion] $COLB One of my longest-held stocks. Had to sell today as CG + captured dividends hit the 100% mark.
[discussion] $COLB Price: $29.09 (-1.12%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.14% RSI
[discussion] $COLB Share Price: $29.56

Contract Selected: Nov 20, 2026 $30 Calls

Buy Zone: $1.87 – $2.31 Target

[discussion] $COLB Current Stock Price: $30.21 Contracts to trade: $30.0 COLB May 15 2026 Call Entry: $0.61 Exit:
[discussion] $COLB Current Stock Price: $29.59 Contracts to trade: $30.0 COLB May 15 2026 Call Entry: $0.20 Exit:
[discussion] [Bullish] $COLB Average ER, but far better than other similar-sized banks. Still bullish to about $3
[discussion] $COLB Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.66 up 60.98% YoY • Reported

[discussion] $COLB Share Price: $26.78

Contract Selected: Nov 20, 2026 $25 Calls

Buy Zone: $3.17 – $3.92 Target

[discussion] $COLB $COLB April 17 $30 calls looking good here. So cheap and earnings coming up.
[discussion] $COLB Share Price: $28.45

Contract Selected: Aug 21, 2026 $30 Calls

Buy Zone: $1.27 – $1.58 Target

[discussion] $COLB Share Price: $32.08

Contract Selected: Aug 21, 2026 $30 Calls

Buy Zone: $2.63 – $3.26 Target

[discussion] [Bullish] $COLB FORTY COMING!
[discussion] $COLB Holding range support. Needs upside breakout. Otherwise sideways action.
[earnings_call] Columbia Banking System, Inc COLB Q4 2025 Earnings Call
[discussion] [Bullish] $COLB And yet the stock price falls -- what the actual F?
[discussion] $COLB just put up a strong Q4 beat — and revenue growth did the heavy lifting 📈 Columbia Banking Sys

Want this on a name you own?Send a ticker; we convene the full council on it.

Request Analysis →

Columbia Banking System, Inc.

COLUMBIA BANKING SYSTEM, INC. (COLB) — Council Assessment

🟡 WATCH · Score 56/100 · medium confidence

360 narrative — news & sentiment digest

Columbia Banking System (COLB) — Investment Briefing

Management Commentary (Q4 2025 Earnings Call)

Recent Developments

Bull Narrative

Bear Narrative

Retail Sentiment

Caveats

Summary

Bull case

Bear case

Dissent — where the council disagrees

Key risks

Catalysts

DCF valuation

Short-sell evaluation

Council scorecard

Member reasoning

Bruce Greenwald — 🟢 pass · 72/100 · medium confidence

AI & Disruption Referee (Christensen-style) — 🟢 pass · 72/100 · medium confidence

Warren Buffett — 🟡 watch · 58/100 · medium confidence

Valuation Referee (Damodaran-style) — 🟡 watch · 58/100 · medium confidence

Benjamin Graham — 🟡 watch · 58/100 · medium confidence

Peter Lynch — 🟡 watch · 58/100 · medium confidence

Howard Marks — 🟡 watch · 55/100 · medium confidence

Michael Mauboussin — 🟡 watch · 55/100 · medium confidence

Ray Dalio — 🟡 watch · 52/100 · medium confidence

Stanley Druckenmiller — 🟡 watch · 52/100 · medium confidence

Seth Klarman — 🟡 watch · 52/100 · medium confidence

Charlie Munger — 🟡 watch · 52/100 · medium confidence

Walter Schloss — 🟡 watch · 52/100 · medium confidence

Forensic Short-Seller (Chanos/Einhorn-style) — 🟡 watch · 52/100 · medium confidence

Chuck Akre — abstained

Philip Fisher — abstained

Joel Greenblatt — abstained

Terry Smith (Fundsmith) — abstained

Fact base appendix

Bruce Greenwald Value

AI & Disruption Referee (Christensen-style) Referee

Warren Buffett Quality

Valuation Referee (Damodaran-style) Referee

Benjamin Graham Value

Peter Lynch Growth

Howard Marks Risk

Michael Mauboussin Quality

Ray Dalio Risk

Stanley Druckenmiller Risk

Seth Klarman Value

Charlie Munger Quality

Walter Schloss Value

Forensic Short-Seller (Chanos/Einhorn-style) Referee